FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/20/2022
Back to search
Official data from USPTO
AM PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/20/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
05/25/2020
Registration date
04/05/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/05/2022
Last transaction
04/05/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
NL
Examiner
MCDORMAN, ROGER
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "AM PHARMA" in blue, separated by a column formed by four green rectangles.
Holders and representatives
Holders
AM-Pharma B.V.
Representatives
Krista Weber Powell Traskbritt, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations for the treatment and prevention of infectious diseasesinflammatory diseaseskidney diseasescancerheart diseasesneurodegenerative diseasesdeficiency diseasesautoimmune diseasesallergies; sanitary preparations for medical use; plasters for medical purposesmaterials for medical and surgical dressings; disinfectants; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseasesinflammatory diseaseskidney diseasescancerheart diseasesneurodegenerative diseasesdeficiency diseasesautoimmune diseasesallergies; pharmaceutical drugs for the treatment of inflammatory diseaseskidney diseasescancerheart diseasesneurodegenerative diseasesdeficiency diseasesautoimmune diseasesallergiesinfectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
Class 42
Scientific and technological services and research and design services related theretoresearch and design in the field of computer datacenter architecture; scientifictechnological and industrial researchscientific researchanalysisreporting in the field of medicine; industrial analysis and industrial research in the field of medicine; development of technologies in the field of diagnosticspharmaceuticals; biotechnological research related to enzymatic synthesis; testing of pharmaceuticals; quality control of goods and services; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research being pharmaceutical drug development services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; medical research and clinical research in the field of inflammatory diseaseskidney diseasescancerheart diseasesneurodegenerative diseasesdeficiency diseasesautoimmune diseasesallergic diseases; scientific research for medical purposesconducting clinical trials; conducting clinical trials for pharmaceutical products of others
Class 44
Services in the field of hygienic and beauty care for human beings
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2022
FIMP
FINAL DISPOSITION PROCESSED
08/25/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/18/2022
PUBO
PUBLISHED FOR OPPOSITION
01/18/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/29/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/29/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/16/2021
GNRT
NON-FINAL ACTION E-MAILED
05/16/2021
CNRT
NON-FINAL ACTION WRITTEN
05/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/13/2021
RFNT
REFUSAL PROCESSED BY IB
12/07/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/18/2020
RFRR
REFUSAL PROCESSED BY MPU
11/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/30/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/28/2020
CNRT
NON-FINAL ACTION WRITTEN
10/27/2020
DOCK
ASSIGNED TO EXAMINER
10/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2020
Continuous trademark protection
Get notified about every new filing that threatens AM PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.